Our comparison of DNA methylation and clinicopathological variables of patients demonstrated that increased methylation of CDH3 is associated with higher tumor stages and grades of differentiation, while no statistical association was seen between CDH3 methylation levels and the state of distant or lymph node metastasis. This evidence concerns the gene CDH3 and neoplasm.